Panacea Index Logo

Command Palette

Search for a command to run...

Comparing effects of beetroot juice and Mediterranean diet on liver enzymes and sonographic appearance in patients with non-alcoholic fatty liver disease: a randomized control trials.

Frontiers in nutrition
May 5, 2023
Hawal Lateef Fateh et al. (5 authors)
Journal ArticleHuman Study
Study Details

Study Goal

The researchers aimed to compare the effects of beetroot juice and the Mediterranean diet on lipid profile, liver enzymes, and liver sonography in patients with non-alcoholic fatty liver disease (NAFLD).

Results Summary

The study found that beetroot juice, both alone and combined with the Mediterranean diet, significantly reduced hepatic steatosis and improved lipid profiles and liver enzyme levels in NAFLD patients. The combination of beetroot juice with the Mediterranean diet showed enhanced efficacy compared to either intervention alone.

Population

180 participants with NAFLD, aged 19-73 years (mean age 45.19 ± 14.94), mean weight 82.46 ± 5.97 kg before intervention.

Effective Dosage

250 mg of beetroot juice.

Duration

12 weeks.

Interactions

None mentioned.

Extracted Claims (24)
InterventionDirectionEndpointPopulationDosageImpactClaim #
Mediterranean diet with beet juice (BJ + MeD)
decrease
Serum Bilirubin
people with NAFLD
-
significantly decreased
#1
Mediterranean diet with beet juice (BJ + MeD)
decrease
alkaline phosphatase (ALP)
people with NAFLD
-
significantly decreased
#2
Mediterranean diet with beet juice (BJ + MeD)
decrease
alanine transaminase (ALT)
people with NAFLD
-
significantly decreased
#3
Mediterranean diet with beet juice (BJ + MeD)
decrease
serum cholesterol (CHOL)
people with NAFLD
-
significantly decreased
#4
Mediterranean diet with beet juice (BJ + MeD)
decrease
triglyceride (TG)
people with NAFLD
-
significantly decreased
#5
Mediterranean diet with beet juice (BJ + MeD)
decrease
low-density lipoprotein (LDL)
people with NAFLD
-
significantly decreased
#6
Mediterranean diet with beet juice (BJ + MeD)
increase
high-density lipoprotein (HDL)
people with NAFLD
-
significantly increased
#7
beetroot juice (BJ)
decrease
Serum Bilirubin
people with NAFLD
-
significantly decreased
#8
beetroot juice (BJ)
decrease
alkaline phosphatase (ALP)
people with NAFLD
-
significantly decreased
#9
beetroot juice (BJ)
decrease
alanine transaminase (ALT)
people with NAFLD
-
significantly decreased
#10
beetroot juice (BJ)
decrease
serum cholesterol (CHOL)
people with NAFLD
-
significantly decreased
#11
beetroot juice (BJ)
decrease
triglyceride (TG)
people with NAFLD
-
significantly decreased
#12
beetroot juice (BJ)
decrease
low-density lipoprotein (LDL)
people with NAFLD
-
significantly decreased
#13
beetroot juice (BJ)
increase
high-density lipoprotein (HDL)
people with NAFLD
-
significantly increased
#14
Mediterranean diet alone (MeD)
decrease
Serum Bilirubin
people with NAFLD
-
significantly decreased
#15
Mediterranean diet alone (MeD)
decrease
alkaline phosphatase (ALP)
people with NAFLD
-
significantly decreased
#16
Mediterranean diet alone (MeD)
decrease
alanine transaminase (ALT)
people with NAFLD
-
significantly decreased
#17
Mediterranean diet alone (MeD)
decrease
serum cholesterol (CHOL)
people with NAFLD
-
significantly decreased
#18
Mediterranean diet alone (MeD)
decrease
triglyceride (TG)
people with NAFLD
-
significantly decreased
#19
Mediterranean diet alone (MeD)
decrease
low-density lipoprotein (LDL)
people with NAFLD
-
significantly decreased
#20
Mediterranean diet alone (MeD)
increase
high-density lipoprotein (HDL)
people with NAFLD
-
significantly increased
#21
Control
decrease
high-density lipoprotein (HDL)
people with NAFLD
-
decreasing
#22
beetroot juice (BJ)
decrease
hepatic steatosis
adults with NAFLD
-
significant reduction
#23
beetroot juice combined with the Mediterranean diet (BJ + MeD)
decrease
hepatic steatosis
adults with NAFLD
-
significant reduction
#24
Abstract

BACKGROUND: In both developed and developing countries, non-alcoholic fatty liver disease (NAFLD) has lately risen to the top of the list of chronic liver illnesses. Although there is no permanent cure, early management, diagnosis, and treatment might lessen its effects. The purpose of conducting the current study is to compare the effects of beetroot juice and the Mediterranean diet on the lipid profile, level of liver enzymes, and liver sonography in patients with NAFLD. METHODS: In this randomized controlled trial, 180 people with a mean age of (45.19 ± 14.94) years participated. Participants ranged in age from 19 to 73. The mean weight before intervention was (82.46 ± 5.97) kg, while the mean weight after intervention was roughly (77.88 ± 6.26) kg. The trial lasted for 12 weeks. The participants were split into four groups: control, a Mediterranean diet with beet juice (BJ + MeD), Mediterranean diet alone (MeD), and beetroot juice (BJ). The Mediterranean diet included fruits, vegetables, fish, poultry, and other lean meats (without skin), sources of omega-3 fatty acids, nuts, and legumes. Beetroot juice had 250 mg of beetroot. Data analysis was done using SPSS software (version 26.0). p < 0.05 is the statistical significance level. RESULTS: Following the intervention, Serum Bilirubin, alkaline phosphatase (ALP), alanine transaminase (ALT), serum cholesterol (CHOL), triglyceride (TG), and low-density lipoprotein (LDL) levels were significantly decreased in the BJ + MeD, BJ, and MeD groups (p = 0.001). Also, high-density lipoprotein (HDL) significantly increased in the BJ + MeD, BJ, and MeD groups (p = 0.001), while decreasing in the Control group (p = 0.001). CONCLUSION: The research findings indicate a significant reduction in hepatic steatosis among the groups receiving beetroot juice (BJ) and beetroot juice combined with the Mediterranean diet (BJ + MeD). This suggests that beetroot juice holds potential as an effective treatment for non-alcoholic fatty liver disease (NAFLD) in adults. Furthermore, the combination of beetroot juice with the Mediterranean diet showed enhanced efficacy in addressing NAFLD.Clinical trial registration: ClinicalTrials.gov, identifier NCT05909631.

Study Links
Quality Scores
SafetyNot Assessed
Efficacy80/10
Quality80/10
Citation Metrics
Total Citations1
Citations/Year0.5
Relative Citation Ratio0.28
NIH Percentile14.4%
Research Impact Scores
APT Score0.05
Weight Score1.22
Normalized Score0.68
Related Supplements